.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Zidovudine - Generic Drug Details

« Back to Dashboard
Zidovudine is the generic ingredient in two branded drugs marketed by Viiv Hlthcare, Mylan Pharms Inc, Ranbaxy Labs Ltd, Aurobindo Pharma Ltd, Matrix Labs Ltd, Liaoning Chengda, Roxane, Cipla Ltd, Luitpold, Sunshine Lake, Cipla, Aurobindo, Hetero Labs Ltd Iii, and Aurobindo Pharma, and is included in nineteen NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-two drug master file entries for zidovudine. Sixteen suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for Generic Name: zidovudine

Tradenames:2
Patents:0
Applicants:14
NDAs:19
Drug Master File Entries: see list22
Suppliers / Packaging: see list16
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details
Drug Prices:see low prices

Tentative approvals for ZIDOVUDINE

Applicant Application No. Form Dosage
<disabled><disabled>CAPSULE; ORAL100MG
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd
ZIDOVUDINE
zidovudine
CAPSULE;ORAL078128-001Mar 27, 2006RXNo► subscribe► subscribe
Viiv Hlthcare
RETROVIR
zidovudine
TABLET;ORAL020518-001Dec 19, 1995DISCNNo► subscribe► subscribe
Cipla
ZIDOVUDINE
zidovudine
TABLET;ORAL090561-001Oct 27, 2010RXNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: zidovudine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Viiv Hlthcare
RETROVIR
zidovudine
CAPSULE;ORAL019655-001Mar 19, 19874,828,838► subscribe
Viiv Hlthcare
RETROVIR
zidovudine
TABLET;ORAL020518-002Oct 4, 19964,724,232► subscribe
Viiv Hlthcare
RETROVIR
zidovudine
CAPSULE;ORAL019655-001Mar 19, 19874,818,538► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc